BFM Group Treatment Results in Relapsed Childhood Acute Lymphoblastic Leukemia

At the first Symposium on Acute Leukemias in SMiinster, 1987, we reported on preliminary results obtained in two subsequent trials on relapsed childhood acute lymphoblastic leukemia, ALL-REZ BFM 83 and 85 [1]. The present paper is an update of the results after both studies have been closed for patient entry and follow-up periods have reached 5 Vi and 3 V2 years, respectively.